FMS News and Press, Fresenius Medical Care AG From 04/05/22

Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office PR Newswire WALTHAM, Mass. , April 5, 2022 /PRNewswire/ -- Fresenius Medical Care , the world's leading provider of products and s...

Laboratory Corporation of America Holdings has exhibited some nice growth over the past few years, driven in large part by the pandemic. This makes the company look deceptively cheap, but when you dig in further, you find shares are still quite attractive. Long-term, this could ma...

The war in Ukraine has overshadowed any other market development in February. I have kept my portfolio intact and made a couple of purchases while divesting one small position. The combination of soaring inflation and geopolitical uncertainty has rattled markets but despite some d...

The Kidney Kid expands its reach to millennial parents through social media campaign Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, has today announced the social media expansion of its highly suc...

We explain why selling cash-covered puts and covered calls is a safer choice and earns a high income. We will discuss how to formulate an options income strategy that's sustainable and repeatable. In this monthly series, we present how to go about selecting the right kind of stock...

Tweedy, Browne’s 13F portfolio value increased from $2.99B to $3.15B this quarter. They increased FMC Corp, Intel Corp, and Fresenius while decreasing Emerson Electric and dropping American Express. Alphabet at ~20% of the portfolio is the largest position. For furthe...

Fresenius Medical Care AG & Co. KGaA. (FMS) Q4 2021 Earnings Conference Call February 22, 2022, 09:00 AM ET Company Participants Dominik Heger - Head of Investor Relations Rice Powell - Chief Executive Officer & Chairman of the Management Board Helen Giza - Chief Financial Officer &am...

Fresenius Medical Care press release (NYSE:FMS): Q4 Non-GAAP EPS of €0.90. Revenue of €4.64B (+5.5% Y/Y). Company expects revenue and net income to grow at low to mid-single digit percentage rates&#x...

Inflation concerns have started to affect market sentiment, but it is highly uncertain if that will lead to a real market correction or just some short-term dips. I am continuing my monthly investment plans while still awaiting a real market correction or possibly a real crash once ma...

FMS, an underfollowed company from Germany, is the world’s leading provider of products and services for patients with renal diseases. It controls the entire value chain from the manufacturing of dialysis equipment to a global network of more than 4,000 dialysis clinics. Th...